Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus: Using insulin glargine as basal insulin

被引：0
|
作者：
Kawamori, Ryuzo
Kadowaki, Takashi
Ishii, Hitoshi
Iwasaki, Manabu
Iwamoto, Yasuhiko
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A573 / A573
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of switching from insulin glargine to insulin degludec in young people with type 1 diabetes
    Urakami, Tatsuhiko
    Kuwabara, Remi
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    ENDOCRINE JOURNAL, 2016, 63 (02) : 159 - 167
  • [42] DIABETES DURATION AND THE EFFICACY AND SAFETY OF INSULIN GLARGINE VERSUS COMPARATOR TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Garg, Satish K.
    Aurand, Lisa A.
    Rimler, Michael S.
    Dailey, George E.
    ENDOCRINE PRACTICE, 2014, 20 (02) : 120 - 128
  • [43] Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients
    Kuroda, Akio
    Tsuruo, Miho
    Takeshi, Kondo
    Aki, Nanako
    Oguro, Yukari
    Endo, Itsuro
    Aihara, Ken-ichi
    Tamaki, Motoyuki
    Matsumoto, Toshio
    Matsuhisa, Munehide
    DIABETES, 2014, 63 : A232 - A232
  • [44] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [45] Efficacy and safety of adding ipragliflozin to insulin in Japanese patients with type 1 diabetes mellitus: a retrospective study
    Shimoda, Masashi
    Mashiko, Akiko
    Katakura, Yukino
    Sanada, Junpei
    Fushimi, Yoshiro
    Obata, Atsushi
    Kimura, Tomohiko
    Kohara, Kenji
    Tatsumi, Fuminori
    Nakanishi, Shuhei
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    ENDOCRINE JOURNAL, 2021, 68 (12) : 1455 - 1461
  • [46] Effectiveness of one-year insulin glargine and insulin glulisine basal-bolus treatment in people with type 2 diabetes
    Jermendy Gyorgy
    Kovacs Gabor
    ORVOSI HETILAP, 2018, 159 (50) : 2122 - 2128
  • [47] Efficacy and safety of switching to insulin icodec, a once-weekly basal insulin, vs insulin glargine U100 in patients with type 2 diabetes inadequately controlled on OADs and basal insulin
    Bajaj, H.
    Isendahl, J.
    Gowda, A.
    Stachlewska, K.
    Rosenstock, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S317 - S317
  • [48] Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
    Freemantle, Nick
    Chou, Engels
    Frois, Christian
    Zhuo, Daisy
    Lehmacher, Walter
    Vlajnic, Aleksandra
    Wang, Hongwei
    Chung, Hsing-wen
    Zhang, Quanwu
    Wu, Eric
    Gerrits, Charles
    BMJ OPEN, 2016, 6 (02):
  • [49] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Kusunoki, Yoshiki
    Katsuno, Tomoyuki
    Miyakoshi, Kana
    Ikawa, Takashi
    Nakae, Rie
    Ochi, Fumihiro
    Tokuda, Masaru
    Akagami, Takafumi
    Murai, Kazuki
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    DIABETES THERAPY, 2013, 4 (02) : 461 - 472
  • [50] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Yoshiki Kusunoki
    Tomoyuki Katsuno
    Kana Miyakoshi
    Takashi Ikawa
    Rie Nakae
    Fumihiro Ochi
    Masaru Tokuda
    Takafumi Akagami
    Kazuki Murai
    Masayuki Miuchi
    Tomoya Hamaguchi
    Jun-ichiro Miyagawa
    Mitsuyoshi Namba
    Diabetes Therapy, 2013, 4 : 461 - 472
12345